Suppr超能文献

颞叶癫痫耐药与非耐药患者血清 ghrelin、nesfatin-1、鸢尾素和血管活性肠肽水平的评估:一项横断面研究。

Evaluation of serum ghrelin, nesfatin-1, irisin, and vasoactive intestinal peptide levels in temporal lobe epilepsy patients with and without drug resistance: a cross-sectional study.

机构信息

Van Yüzüncü Yıl University, Faculty of Medicine, Department of Physiology - Van, Turkey.

Van Yüzüncü Yıl University, Faculty of Medicine, Department of Neurology - Van, Turkey.

出版信息

Rev Assoc Med Bras (1992). 2021 Feb;67(2):207-212. doi: 10.1590/1806-9282.67.02.20200521.

Abstract

OBJECTIVE

Epilepsy is a common disorder that affects the nervous systems of 1% of worldwide population. In epilepsy, one-third of patients are unresponsive to current drug therapies and develop drug-resistant epilepsy. Alterations in ghrelin, nesfatin-1, and irisin levels with epilepsy were reported in previous studies. Vasoactive intestinal peptide is among the most common neuropeptides in the hippocampus, which is the focus of the seizures in temporal lobe epilepsy. However, there is also lack of evidence of whether these four neuropeptide levels are altered with drug resistant temporal lobe epilepsy or not. The aim herein was the evaluation of the serum levels of nesfatin-1, ghrelin, irisin, and Vasoactive intestinal peptide in drug-resistant temporal lobe epilepsy patients and temporal lobe epilepsy (TLE) without drug resistance, and to compare them to healthy controls.

METHODS

This cross-sectional study group included 58 temporal lobe epilepsy patients (24 with drug resistant temporal lobe epilepsy and 34 with temporal lobe epilepsy who were not drug-resistant) and 28 healthy subjects. Nesfatin-1, ghrelin, irisin, and Vasoactive intestinal peptide serum levels were determined using enzyme-linked immunosorbent assay.

RESULTS

The serum ghrelin levels of patients with drug resistant temporal lobe epilepsy were seen to have significantly decreased when compared to those of the control group (p<0.05). Serum nesfatin-1, vasoactive intestinal peptide, and irisin levels were seen to have decreased in the drug resistant temporal lobe epilepsy group when compared to those of the control and temporal lobe epilepsy groups; however, the difference was non-significant (p>0.05).

CONCLUSIONS

The results herein suggested that ghrelin might contribute to the pathophysiology of drug resistant temporal lobe epilepsy. However, further studies are needed to confirm this hypothesis.

摘要

目的

癫痫是一种常见的神经系统疾病,影响着全球 1%的人口。在癫痫患者中,有三分之一的患者对现有药物治疗反应不佳,发展为耐药性癫痫。先前的研究报道了癫痫患者中 ghrelin、nesfatin-1 和 irisin 水平的改变。血管活性肠肽是海马体中最常见的神经肽之一,海马体是颞叶癫痫发作的焦点。然而,也缺乏证据表明这些四种神经肽水平是否与耐药性颞叶癫痫有关。本研究旨在评估耐药性颞叶癫痫患者和非耐药性颞叶癫痫(TLE)患者血清中 nesfatin-1、ghrelin、irisin 和血管活性肠肽水平,并将其与健康对照组进行比较。

方法

本横断面研究包括 58 例颞叶癫痫患者(24 例耐药性颞叶癫痫,34 例非耐药性颞叶癫痫)和 28 例健康对照者。采用酶联免疫吸附试验测定血清 nesfatin-1、ghrelin、irisin 和血管活性肠肽水平。

结果

耐药性颞叶癫痫患者的血清 ghrelin 水平明显低于对照组(p<0.05)。与对照组和 TLE 组相比,耐药性颞叶癫痫组的血清 nesfatin-1、血管活性肠肽和 irisin 水平降低,但差异无统计学意义(p>0.05)。

结论

本研究结果提示 ghrelin 可能参与耐药性颞叶癫痫的病理生理学过程。然而,需要进一步的研究来证实这一假设。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验